Alliance Pharma Management Update
Alliance Pharma plc (AIM: APH), the international healthcare group, announces that Peter Butterfield, Chief Executive Officer, is taking time away from the business for personal reasons. He is expected to return during January 2023.
Andrew Franklin, Chief Financial Officer, has assumed Peter’s CEO responsibilities, in line with the Group’s established resilience plans, with support from the Head of Finance and the wider leadership team.
For further information:
Alliance Pharma plc
+ 44 (0)1249 466966
Cora McCallum, Head of Investor Relations & Corporate Communications
+ 44 (0)1249 705168